James B. Weissman
2015
In 2015, James B. Weissman earned a total compensation of $1.4M as Chief Business Officer at Dicerna Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $102,071 |
|---|---|
| Option Awards | $872,903 |
| Salary | $363,500 |
| Other | $18,660 |
| Total | $1,357,134 |
Weissman received $872.9K in option awards, accounting for 64% of the total pay in 2015.
Weissman also received $102.1K in non-equity incentive plan, $363.5K in salary and $18.7K in other compensation.
Rankings
In 2015, James B. Weissman's compensation ranked 6,468th out of 13,638 executives tracked by ExecPay. In other words, Weissman earned more than 52.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,468 out of 13,638 | 53rd |
Division Manufacturing | 2,426 out of 5,190 | 53rd |
Major group Chemicals And Allied Products | 877 out of 1,854 | 53rd |
Industry group Drugs | 702 out of 1,528 | 54th |
Industry Pharmaceutical Preparations | 549 out of 1,182 | 54th |
Source: SEC filing on April 29, 2016.
Weissman's colleagues
We found two more compensation records of executives who worked with James B. Weissman at Dicerna Pharmaceuticals in 2015.